cobalt has been researched along with 12-o-retinoylphorbol-13-acetate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biswas, S; Kumar, N; Nayak, PG; Rao, CM; Reddy, ND; Shoja, MH | 1 |
1 other study(ies) available for cobalt and 12-o-retinoylphorbol-13-acetate
Article | Year |
---|---|
An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDACÂ inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells.
Topics: A549 Cells; Acetylation; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cobalt; Cyclin-Dependent Kinase Inhibitor p21; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells; Phorbol Esters; Poly(ADP-ribose) Polymerases; Sulfonamides; Tubulin; Tumor Suppressor Protein p53 | 2016 |